Predictors of anti-vascular endothelial growth factor treatment responses in macular edema following central vein occlusion

被引:1
|
作者
Huang Peirong [1 ]
Song Zhengyu [2 ]
Sun Xiaodong [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200080, Peoples R China
[2] Shanghai Jiao Tong Univ, Eye Res Inst, Shanghai Key Lab Fundus Dis, Shanghai 200080, Peoples R China
基金
中国国家自然科学基金;
关键词
retinal vein occlusion; macular edema; vascular endothelial growth factor; visual acuity; OPTICAL COHERENCE TOMOGRAPHY; RANIBIZUMAB; BEVACIZUMAB; INJECTION; SECONDARY; OUTCOMES; NEOVASCULARIZATION; PREVALENCE; MANAGEMENT; DISORDERS;
D O I
10.3760/cma.j.issn.0366-6999.20140006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:3019 / 3023
页数:5
相关论文
共 50 条
  • [1] Predictors of anti-vascular endothelial growth factor treatment responses in macular edema following central vein occlusion
    Huang Peirong
    Song Zhengyu
    Sun Xiaodong
    中华医学杂志(英文版), 2014, (16) : 3019 - 3023
  • [2] Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion
    Braithwaite, T.
    Nanji, A. A.
    Greenberg, P. B.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (10):
  • [3] Predictors of Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion
    Sen, Piyali
    Gurudas, Sarega
    Ramu, Jayashree
    Patrao, Namritha
    Chandra, Shruti
    Rasheed, Rajna
    Nicholson, Luke
    Peto, Tunde
    Sivaprasad, Sobha
    Hykin, Philip
    OPHTHALMOLOGY RETINA, 2021, 5 (11): : 1115 - 1124
  • [4] Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
    Mashima, Asako
    Noma, Hidetaka
    Yasuda, Kanako
    Goto, Hiroshi
    Shimura, Masahiko
    JOURNAL OF INFLAMMATION-LONDON, 2019, 16 (1):
  • [5] Anti-vascular endothelial growth factor agents reduce inflammation in central retinal vein occlusion with macular edema
    Noma, Hidetaka
    Yasuda, Kanako
    Shimura, Masahiko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [6] Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
    Asako Mashima
    Hidetaka Noma
    Kanako Yasuda
    Hiroshi Goto
    Masahiko Shimura
    Journal of Inflammation, 16
  • [7] Cost-Utility of Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion
    Lin, James
    Gibbons, Allister
    Smiddy, William E.
    OPHTHALMOLOGY RETINA, 2021, 5 (07): : 656 - 663
  • [8] Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion
    Braithwaite, Tasanee
    Nanji, Afshan A.
    Lindsley, Kristina
    Greenberg, Paul B.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (05):
  • [9] Anti-vascular endothelial growth factor treatment in diabetic macular edema
    Kim, Moosang
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1355 - 1356
  • [10] A Meta-Analysis of Anti-Vascular Endothelial Growth Factor Remedy for Macular Edema Secondary to Central Retinal Vein Occlusion
    Huang, Peirong
    Niu, Wenquan
    Ni, Zhentian
    Wang, Renzuo
    Sun, Xiaodong
    PLOS ONE, 2013, 8 (12):